MODD
Modular Medical, Inc.·Healthcare
4.91
2.191%(−0.11)
Market ClosedLast Updated: — ET
52W L: $3.5452W H: $34.50
MODD NEWS
accessnewswire.com
2d ago
Modular Medical Receives FDA 510(k) Clearance for Pivot Tubeless Insulin Patch Pump
First Removable 2-Part Design Targets $3 Billion "Almost-Pumper" Market with Expected Q2 2026 initial deployment. Key Milestones & Investment Highlights: FDA 510(k) Clearance Achieved: Pivot™ pump now cleared for commercial sale in the U.S. - major de-risking event unlocking revenue path.
defenseworld.net
Mar 28
Financial Comparison: Modular Medical (NASDAQ:MODD) and EssilorLuxottica (OTCMKTS:ESLOY)
EssilorLuxottica (OTCMKTS:ESLOY - Get Free Report) and Modular Medical (NASDAQ: MODD - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, institutional ownership, earnings, valuation, risk and analyst recommendations. Analyst Ratings This is a summary of recent ratings
accessnewswire.com
Mar 26
Modular Medical Announces 1-for-30 Reverse Stock Split
SAN DIEGO, CA / ACCESS Newswire / March 26, 2026 / Modular Medical, Inc. ("Modular Medical" or the "Company") (NASDAQ:MODD), an innovative insulin delivery technology company, today announced that it will effect a 1-for-30 reverse stock split of its outstanding common stock. The reverse stock split will become effective at 5:30am ET on March 31, 2026.
accessnewswire.com
Mar 3
Modular Medical Announces $12.0 Million Public Offering Priced at a Premium to Market
SAN DIEGO, CA / ACCESS Newswire / March 3, 2026 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and affordable design, today announced the pricing of a public offering with new and existing investors of 68,098,000 shares of its common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to an aggregate of 68,098,000 shares of its common stock at a combined public offering price of $0.1762 per share (or pre-funded warrant) and accompanying warrant. The warrants will have an exercise price of $0.1762 per share, will be exercisable immediately, and will expire five years from the date of issuance.
accessnewswire.com
Feb 4
Modular Medical Achieves Key Manufacturing Milestone for Pivot Tubeless Insulin Patch Pump
Targeting Q1 2026 Launch, Subject to FDA Clearance Key Highlights: Cartridge & Infusion Set Lots in Production: Validation production lots now being produced for launch, derisking commercial-scale production. First Removable Tubeless Patch Pump: Pivot targets underserved "almost-pumpers" - adults with diabetes hesitant to move from multiple daily injections (MDI) due to cost and complexity - representing a significant portion of the growing ~$8 billion global insulin pump market.
